KRAS Subtype Modifies Outcomes with Immunomodulatory Therapy in Advanced Pancreatic Ductal Adenocarcinoma: Evidence from Early-Phase Trials. - Mizrak Kaya, Dilsa; Ma, Yangruijue; Demir, Tarik; Altomare, Nicole J.; Kalyan, Aparna; Kircher, Sheetal; Mulcahy, Mary; Benson III, Al B.; Chen, Ruohui; Mahalingam, Devalingam (Cancers, 2026)